96-813. Findings of Scientific Misconduct  

  • [Federal Register Volume 61, Number 15 (Tuesday, January 23, 1996)]
    [Notices]
    [Page 1765]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-813]
    
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Office of the Secretary
    
    
    Findings of Scientific Misconduct
    
    AGENCY: Office of the Secretary, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: Notice is hereby given that the Office of Research Integrity 
    (ORI) has made final findings of scientific misconduct in the following 
    case:
        Durga K. Paruchuri, Ph.D., University of North Carolina, Chapel 
    Hill: Based on an investigation conducted by the University of North 
    Carolina, Chapel Hill (UNC), and information obtained during its 
    oversight review, the Office of Research Integrity (ORI), concluded 
    that Dr. Durga K. Paruchuri committed scientific misconduct by 
    falsifying research records and falsely reporting to her supervisor and 
    in a grant application submitted to the Public Health Service (PHS) 
    that she had produced a clone of meningococcal bacteria transferrin 
    binding protein 1, labeled ``pUNCH 701,'' and used it to obtain a 
    second clone, ``pUNCH 702.'' Furthermore, ORI accepted the UNC finding 
    that Dr. Paruchuri falsified research records at the Lineberger Cancer 
    Research Center oligonucleotide synthesis facility in an attempt to 
    support her false claim. The research was supported by PHS grant R37 
    AI26837 and reported in grant application 1 RO1 AI32115-01A1.
        Dr. Paruchuri accepted the ORI findings and agreed to exclude 
    herself voluntarily for a period of two years beginning December 21, 
    1995, from any contracting or subcontracting with any agency of the 
    United States Government and from eligibility for, or involvement in 
    nonprocurement transactions (e.g., grants and cooperative agreements) 
    of the United States Government. Dr. Paruchuri further agreed that for 
    a period of one year in addition to and immediately following the two 
    year exclusion period, any institution which submits an application for 
    PHS support for a research project on which Dr. Paruchuri's 
    participation is proposed, or which uses Dr. Paruchuri in any capacity 
    on PHS supported research, or which submits a report of PHS funded 
    research in which Dr. Paruchuri is involved, must concurrently submit a 
    plan of supervision and certification of data accuracy. Dr. Paruchuri 
    also agreed to exclude herself voluntarily from serving in any advisory 
    capacity to the PHS for a period of three years beginning December 21, 
    1995.
    
    FOR FURTHER INFORMATION, CONTACT: Director, Division of Research 
    Investigations, Office of Research Integrity, 301-443-5330.
    Lyle W. Bivens,
    Director, Office of Research Integrity.
    [FR Doc. 96-813 Filed 1-22-96; 8:45 am]
    BILLING CODE 4160-17-P
    
    

Document Information

Published:
01/23/1996
Department:
Health and Human Services Department
Entry Type:
Notice
Action:
Notice.
Document Number:
96-813
Pages:
1765-1765 (1 pages)
PDF File:
96-813.pdf